Omega-3 fatty acids and cardiovascular disease: Epidemiology and effects on cardiometabolic risk factors

Food and Function

Volumn 5, Issue 9, 2014, Pages 2004-2019

  Mori, Trevor A ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD PRESSURE; CARDIOLOGY; DISEASES; DRUG DOSAGE; FATTY ACIDS; FISH; PATIENT TREATMENT;

CARDIO-VASCULAR DISEASE; CORONARY HEART DISEASE; EICOSAPENTAENOIC ACID; EPIDEMIOLOGICAL STUDIES; FRUITS AND VEGETABLES; GENERAL PRACTITIONERS; PRACTICAL RECOMMENDATION; SECONDARY PREVENTION;

POLYUNSATURATED FATTY ACIDS;

OMEGA 3 FATTY ACID;

ANALYSIS; ANIMAL; CARDIOVASCULAR DISEASES; DIET SUPPLEMENTATION; FISH; HUMAN; METABOLISM; RISK FACTOR;

ANIMALS; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FISHES; HUMANS; RISK FACTORS;

EID: 84906572881     PISSN: 20426496     EISSN: 2042650X     Source Type: Journal    
DOI: 10.1039/c4fo00393d     Document Type: Review

References (152)

1. H. O. Bang J. Dyerberg A. B. Nielson Plasma Lipid and Lipoprotein Pattern in Greenlandic West-Coast Eskimos Lancet 1971 1 1143 1146
2. H. O. Bang J. Dyerberg N. Hjorne Composition of Food Consumed by Greenland Eskimos Acta Med. Scand. 1976 200 69 73
3. H. O. Bang J. Dyerberg H. M. Sinclair The Composition of the Eskimo Food in Northwestern Greenland Am. J. Clin. Nutr. 1980 33 2657 2661
4. M. Wada C. J. DeLong Y. H. Hong C. J. Rieke I. Song R. S. Sidhu C. Yuan M. Warnock A. H. Schmaier C. Yokoyama E. M. Smyth S. J. Wilson G. A. FitzGerald R. M. Garavito D. X. Sui J. W. Regan W. L. Smith Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acid-derived substrates and products J. Biol. Chem. 2007 282 22254 22266
5. S. P. Tull C. M. Yates B. H. Maskrey V. B. O'Donnell J. Madden R. F. Grimble P. C. Calder G. B. Nash G. E. Rainger Omega-3 Fatty acids and inflammation: novel interactions reveal a new step in neutrophil recruitment PLoS Biol. 2009 7 e1000177
6. J. T. Brenna N. Salem A. J. Sinclair S. C. Cunnane alpha-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans Prostaglandins, Leukotrienes Essent. Fatty Acids 2009 80 85 91
7. F. N. Hepburn J. Exler J. L. Weihrauch Provisional tables on the content of omega-3 fatty acids and other fat components of selected foods J. Am. Diet. Assoc. 1986 86 788 793
8. H. C. Bucher P. Hengstler C. Schindler G. Meier N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials Am. J. Med. 2002 112 298 304
9. K. He Y. Q. Song M. L. Daviglus K. Liu L. Van Horn A. R. Dyer P. Greenland Accumulated evidence on fish consumption and coronary heart disease mortality-A meta-analysis of cohort studies Circulation 2004 109 2705 2711
10. C. C. Wang W. S. Harris M. Chung A. H. Lichtenstein E. M. Balk B. Kupelnick H. S. Jordan J. Lau n-3 fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review Am. J. Clin. Nutr. 2006 84 5 17
11. S. P. Whelton J. He P. K. Whelton P. Muntner Meta-analysis of observational studies on fish intake and coronary heart disease Am. J. Cardiol. 2004 93 1119 1123
12. P. E. Marik J. Varon Omega-3 Dietary Supplements and the Risk of Cardiovascular Events: A Systematic Review Clin. Cardiol. 2009 32 365 372
13. K. Musa-Veloso M. A. Binns A. Kocenas C. Chung H. Rice H. Oppedal-Olsen H. Lloyd S. Lemke Impact of low v. moderate intakes of long-chain n-3 fatty acids on risk of coronary heart disease Br. J. Nutr. 2011 106 1129 1141
14. Y. T. Zhao Q. Chen Y. X. Sun X. B. Li P. Zhang Y. Xu J. H. Guo Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials Ann. Med. 2009 41 301 310
15. E. C. Rizos E. E. Ntzani E. Bika M. S. Kostapanos M. S. Elisaf Association Between Omega-3 Fatty Acid Supplementation and Risk of Major Cardiovascular Disease Events A Systematic Review and Meta-analysis JAMA, J. Am. Med. Assoc. 2012 308 1024 1033
16. S. Kotwal M. Jun D. Sullivan V. Perkovic B. Neal Omega 3 Fatty Acids and Cardiovascular Outcomes Systematic Review and Meta-Analysis Circ. Cardiovasc Qual. Outcomes 2012 5 808 818
17. S. M. Kwak S. K. Myung Y. J. Lee H. G. Seo Efficacy of omega-3 fatty acid supplements (eicosapentaenoic acid and docosahexaenoic acid) in the secondary prevention of cardiovascular disease: a meta-analysis of randomized, double-blind, placebo-controlled trials Arch. Intern. Med. 2012 172 686 694
18. E. B. Levitan A. Wolk M. A. Mittleman Fish consumption, marine omega-3 fatty acids, and incidence of heart failure: a population-based prospective study of middle-aged and elderly men Eur. Heart J. 2009 30 1495 1500
19. L. Djousse A. O. Akinkuolie J. H. Y. Wu E. L. Ding J. M. Gaziano Fish consumption, omega-3 fatty acids and risk of heart failure: A meta-analysis Clin. Nutr. 2012 31 846 853
20. D. Mozaffarian C. L. Bryson R. N. Lemaitre G. L. Burke D. S. Siscovick Fish intake and risk of incident heart failure J. Am. Coll. Cardiol. 2005 45 2015 2021
21. D. Mozaffarian B. M. Psaty E. B. Rimm R. N. Lemaitre G. L. Burke M. F. Lyles D. Lefkowitz D. S. Siscovick Fish intake and risk of incident atrial fibrillation Circulation 2004 110 368 373
22. J. K. Virtanen J. Mursu S. Voutilainen T. P. Tuomainen Serum Long-Chain n-3 Polyunsaturated Fatty Acids and Risk of Hospital Diagnosis of Atrial Fibrillation in Men Circulation 2009 120 2315 2321
23. J. H. Y. Wu R. N. Lemaitre I. B. King X. L. Song F. M. Sacks E. B. Rimm S. R. Heckbert D. S. Siscovick D. Mozaffarian Association of Plasma Phospholipid Long-Chain Omega-3 Fatty Acids With Incident Atrial Fibrillation in Older Adults The Cardiovascular Health Study Circulation 2012 125 1084 U1071
24. L. Frost P. Vestergaard n-3 Fatty acids consumed from fish and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study Am. J. Clin. Nutr. 2005 81 50 54
25. N. N. Gronroos A. M. Chamberlain A. R. Folsom E. Z. Soliman S. K. Agarwal J. A. Nettleton A. Alonso Fish, Fish-Derived n-3 Fatty Acids, and Risk of Incident Atrial Fibrillation in the Atherosclerosis Risk in Communities (ARIC) Study PLoS One 2012 7 e36686
26. R. G. Metcalf G. V. Skuladottir O. S. Indridason T. R. Sullivan L. Bjorgvinsdottir P. Sanders D. O. Arnar R. A. Gibson R. Heidarsdottir L. G. Cleland R. Palsson A. L. Farquharson G. D. Young M. J. James U-shaped relationship between tissue docosahexaenoic acid and atrial fibrillation following cardiac surgery Eur. J. Clin. Nutr. 2014 68 114 118
27. T. A. Rix A. M. Joensen S. Riahi S. Lundbye-Christensen A. Tjonneland E. B. Schmidt K. Overvad A U-shaped association between consumption of marine n-3 fatty acids and development of atrial fibrillation/atrial flutter-a Danish cohort study Europace 2014 10.1093/europace/euu019
28. K. He Y. Q. Song M. L. Daviglus K. Liu L. Van Horn A. R. Dyer U. Goldbourt P. Greenland Fish consumption and incidence of stroke-A meta-analysis of cohort studies Stroke 2004 35 1538 1542
29. P. Xun B. Qin Y. Song Y. Nakamura T. Kurth S. Yaemsiri L. Djousse K. He Fish consumption and risk of stroke and its subtypes: accumulative evidence from a meta-analysis of prospective cohort studies Eur. J. Clin. Nutr. 2012 66 1199 1207
30. M. L. Burr J. F. Gilbert R. M. Holliday P. C. Elwood A. M. Fehily S. Rogers P. M. Sweetnam N. M. Deadman Effects of Changes in Fat, Fish, and Fiber Intakes on Death and Myocardial Reinfarction-Diet and Reinfarction Trial (Dart) Lancet 1989 2 757 761
31. F. Valagussa M. G. Franzosi E. Geraci N. Mininni G. L. Nicolosi M. Santini L. Tavazzi C. Vecchio R. Marchioli E. Bomba C. Chieffo A. P. Maggioni C. Schweiger G. Tognoni F. Barzi A. V. Flamminio R. M. Marfisi M. Olivieri C. Pera A. Polidoro E. Santoro R. Zama L. Pagliaro E. Correale A. Del Favero U. Loi E. Marubini L. Campolo A. Casari G. Di Minno M. B. Donati M. Galli M. Gattone S. Garattini M. Mancini P. Marino G. M. Santoro C. Scardulla G. Specchia A. Cericola D. Di Gregorio R. Di Mascio G. Levantesi L. Mantini G. Mastrogiuseppe C. Tucci P. Mocarelli R. Baldinelli F. Ceriotti A. Colonna C. Cortese G. Fortunato C. Franzini F. Gonano M. S. Graziani G.-P. Investigators Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial Lancet 1999 354 447 455
32. L. Tavazzi A. P. Maggioni R. Marchioli S. Barlera M. G. Franzosi R. Latini D. Lucci G. L. Nicolosi M. Porcu G. Tognoni G. H. Investigators Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial Lancet 2008 372 1223 1230
33. M. Yokoyama H. Origasa M. Matsuzaki Y. Matsuzawa Y. Saito Y. Ishikawa S. Oikawa J. Sasaki H. Hishida H. Itakura T. Kita A. Kitabatake N. Nakaya T. Sakata K. Shimada K. Shirato J. Investigators Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised openlabel, blinded endpoint analysis Lancet 2007 369 1090 1098
34. D. Mozaffarian R. Marchioli A. Macchia M. G. Silletta P. Ferrazzi T. J. Gardner R. Latini P. Libby F. Lombardi P. T. O'Gara R. L. Page L. Tavazzi G. Tognoni O. Investigators Fish Oil and Postoperative Atrial Fibrillation The Omega-3 Fatty Acids for Prevention of Post-operative Atrial Fibrillation (OPERA) Randomized Trial JAMA, J. Am. Med. Assoc. 2012 308 2001 2011
35. J. Bosch H. C. Gerstein G. R. Dagenais R. Diaz L. Dyal H. Jung A. P. Maggiono J. Probstfield A. Ramachandran M. C. Riddle L. E. Ryden S. Yusuf n-3 Fatty Acids and Cardiovascular Outcomes in Patients with Dysglycemia N. Engl. J. Med. 2012 367 309 318
36. M. C. Roncaglioni M. Tombesi F. Avanzini S. Barlera V. Caimi P. Longoni I. Marzona V. Milani M. G. Silletta G. Tognoni R. Marchioli R. P. S. Collaborativ n-3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors New Engl. J. Med. 2013 368 1800 1808
37. W. S. Harris B. Assaad W. C. Poston Tissue omega-6/omega-3 fatty acid ratio and risk for coronary artery disease Am. J. Cardiol. 2006 98 19i 26i
38. E. B. Schmidt H. Arnesen R. de Caterina L. H. Rasmussen S. D. Kristensen Marine n-3 polyunsaturated fatty acids and coronary heart disease-Part I. Background, epidemiology, animal data, effects on risk factors and safety Thromb. Res. 2005 115 163 170
39. E. B. Schmidt H. Arnesen J. H. Christensen L. H. Rasmussen S. D. Kristensen R. De Caterina Marine n-3 polyunsaturated fatty acids and coronary heart disease-Part II: Clinical trials and recommendations Thromb. Res. 2005 115 257 262
40. T. A. Mori L. J. Beilin Long-chain omega 3 fatty acids, blood lipids and cardiovascular risk reduction Curr. Opin. Lipidol. 2001 12 11 17
41. D. Mozaffarian J. H. Wu Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events J. Am. Coll. Cardiol. 2011 58 2047 2067
42. L. J. Appel E. R. Miller A. J. Seidler P. K. Whelton Does Supplementation of Diet with Fish-Oil Reduce Blood-Pressure-a Metaanalysis of Controlled Clinical-Trials Arch. Intern. Med. 1993 153 1429 1438
43. J. M. Geleijnse E. J. Giltay D. E. Grobbee A. R. T. Donders F. J. Kok Blood pressure response to fish oil supplementation: metaregression analysis of randomized trials J. Hypertens. 2002 20 1493 1499
44. T. A. Mori, V. Burke and L. J. Beilin, Dietary Fats and Blood Pressure, Elsevier, Philadelphia, 2007
45. M. C. Morris F. Sacks B. Rosner Does Fish-Oil Lower Blood-Pressure-a Metaanalysis of Controlled Trials Circulation 1993 88 523 533
46. G. E. Mcveigh G. M. Brennan J. N. Cohn S. M. Finkelstein R. J. Hayes G. D. Johnston Fish-Oil Improves Arterial Compliance in Non-Insulin-Dependent Diabetes-Mellitus Arterioscler. Thromb. 1994 14 1425 1429
47. P. Nestel H. Shige S. Pomeroy M. Cehun M. Abbey D. Raederstorff The n-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid increase systemic arterial compliance in humans Am. J. Clin. Nutr. 2002 76 326 330
48. J. P. Chin Marine oils and cardiovascular reactivity Prostaglandins, Leukotrienes Essent. Fatty Acids 1994 50 211 222
49. T. A. Mori G. F. Watts V. Burke E. Hilme I. B. Puddey L. J. Beilin Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men Circulation 2000 102 1264 1269
50. W. S. Harris n-3 fatty acids and lipoproteins: comparison of results from human and animal studies Lipids 1996 31 243 252
51. W. S. Harris n-3 fatty acids and serum lipoproteins: human studies Am. J. Clin. Nutr. 1997 65 1645S 1654S
52. H. R. Knapp Dietary fatty acids in human thrombosis and hemostasis Am. J. Clin. Nutr. 1997 65 S1687 S1698
53. P. C. Calder The role of marine omega-3 (n-3) fatty acids in inflammatory processes, atherosclerosis and plaque stability Mol. Nutr. Food Res. 2012 56 1073 1080
54. P. C. Calder Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology? Br. J. Clin. Pharmacol. 2013 75 645 662
55. T. A. Mori L. J. Beilin Omega-3 fatty acids and inflammation Curr. Atheroscler. Rep. 2004 6 461 467
56. C. N. Serhan N. A. Petasis Resolvins and protectins in inflammation resolution Chem. Rev. 2011 111 5922 5943
57. E. Mas R. J. Woodman V. Burke I. B. Puddey L. J. Beilin T. Durand T. A. Mori The omega-3 fatty acids EPA and DHA decrease plasma F(2)-isoprostanes: Results from two placebo-controlled interventions Free Radical Res. 2010 44 983 990
58. T. A. Mori R. J. Woodman The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans Curr. Opin. Clin. Nutr. Metab. Care 2006 9 95 104
59. T. A. Mori V. Burke I. B. Puddey G. F. Watts D. N. O'Neal J. D. Best L. J. Beilin Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperlipidemic men Am. J. Clin. Nutr. 2000 71 1085 1094
60. R. J. Woodman T. A. Mori V. Burke I. B. Puddey G. F. Watts L. J. Beilin Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension Am. J. Clin. Nutr. 2002 76 1007 1015
61. W. S. Harris D. Bulchandani Why do omega-3 fatty acids lower serum triglycerides? Curr. Opin. Lipidol. 2006 17 387 393
62. A. J. Cussons G. F. Watts T. A. Mori B. G. Stuckey Omega-3 fatty acid supplementation decreases liver fat content in polycystic ovary syndrome: a randomized controlled trial employing proton magnetic resonance spectroscopy J. Clin. Endocrinol. Metab. 2009 94 3842 3848
63. T. A. Mori D. Q. Bao V. Burke I. B. Puddey G. F. Watts L. J. Beilin Dietary fish as a major component of a weight-loss diet: effect on serum lipids, glucose, and insulin metabolism in overweight hypertensive subjects Am. J. Clin. Nutr. 1999 70 817 825
64. R. J. Woodman T. A. Mori V. Burke I. B. Puddey G. F. Watts J. D. Best L. J. Beilin Docosahexaenoic acid but not eicosapentaenoic acid increases LDL particle size in treated hypertensive type 2 diabetic patients Diabetes Care 2003 26 253
65. J. Hulthe L. Bokemark J. Wikstrand B. Fagerberg The metabolic syndrome, LDL particle size, and atherosclerosis-The atherosclerosis and insulin resistance (AIR) study Arterioscler., Thromb., Vasc. Biol. 2000 20 2140 2147
66. S. Lahdenpera M. Syvanne J. Kahri M. R. Taskinen Regulation of low-density lipoprotein particle sire distribution in NIDDM and coronary disease: Importance of serum triglycerides Diabetologia 1996 39 453 461
67. D. C. Chan G. F. Watts T. A. Mori P. H. Barrett L. J. Beilin T. G. Redgrave Factorial study of the effects of atorvastatin and fish oil on dyslipidaemia in visceral obesity Eur. J. Clin. Invest. 2002 32 429 436
68. R. S. Dokholyan C. M. Albert L. J. Appel N. R. Cook P. Whelton C. H. Hennekens A trial of omega-3 fatty acids for prevention of hypertension Am. J. Cardiol. 2004 93 1041 1043
69. H. O. Dickinson J. M. Mason D. J. Nicolson F. Campbell F. R. Beyer J. V. Cook B. Williams G. A. Ford Lifestyle interventions to reduce raised blood pressure: a systematic review of randomized controlled trials J. Hypertens. 2006 24 215 233
70. L. Cobiac P. J. Nestel L. M. Wing P. R. Howe A low-sodium diet supplemented with fish oil lowers blood pressure in the elderly J. Hypertens. 1992 10 87 92
71. P. Singer S. Melzer M. Goschel S. Augustin Fish Oil Amplifies the Effect of Propranolol in Mild Essential-Hypertension Hypertension 1990 16 682 691
72. Y. K. Lungershausen M. Abbey P. J. Nestel P. R. Howe Reduction of blood pressure and plasma triglycerides by omega-3 fatty acids in treated hypertensives J. Hypertens. 1994 12 1041 1045
73. D. Q. Bao T. A. Mori V. Burke I. B. Puddey L. J. Beilin Effects of dietary fish and weight reduction on ambulatory blood pressure in overweight hypertensives Hypertension 1998 32 710 717
74. T. A. Mori D. Q. Bao V. Burke I. B. Puddey L. J. Beilin Docosahexaenoic acid but not eicosapentaenoic acid lowers ambulatory blood pressure and heart rate in humans Hypertension 1999 34 253 260
75. S. Grimsgaard K. H. Bonaa J. B. Hansen E. S. P. Myhre Effects of highly purified eicosapentaenoic acid and docosahexaenoic acid on hemodynamics in humans Am. J. Clin. Nutr. 1998 68 52 59
76. Z. M. Chu K. Yin L. J. Beilin Fish oil feeding selectively attenuates contractile responses to noradrenaline and electrical stimulation in the perfused mesenteric resistance vessels of spontaneously hypertensive rats Clin. Exp. Pharmacol. Physiol. 1992 19 177 181
77. K. Yin Z. M. Chu L. J. Beilin Blood pressure and vascular reactivity changes in spontaneously hypertensive rats fed fish oil Br. J. Pharmacol. 1991 102 991 997
78. J. P. Chin A. P. Gust A. M. Dart Indomethacin inhibits the effects of dietary supplementation with marine oils on vasoconstriction of human forearm resistance vessels in vivo J. Hypertens. 1993 11 1229 1234
79. J. P. F. Chin A. M. Dart Therapeutic Restoration of Endothelial Function in Hypercholesterolemic Subjects-Effect of Fish Oils Clin. Exp. Pharmacol. Physiol. 1994 21 749 755
80. G. E. Mcveigh G. M. Brennan G. D. Johnston B. J. Mcdermott L. T. Mcgrath W. R. Henry J. W. Andrews J. R. Hayes Dietary Fish Oil Augments Nitric-Oxide Production or Release in Patients with Type-2 (Non-Insulin-Dependent) Diabetes-Mellitus Diabetologia 1993 36 33 38
81. M. B. Engler M. M. Engler P. C. Ursell Vasorelaxant properties of n-3 polyunsaturated fatty acids in aortas from spontaneously hypertensive and normotensive rats J. Cardiovasc. Risk 1994 1 75 80
82. P. McLennan P. Howe M. Abeywardena R. Muggli D. Raederstorff M. Mano T. Rayner R. Head The cardiovascular protective role of docosahexaenoic acid Eur. J. Pharmacol. 1996 300 83 89
83. W. S. Harris G. S. Rambjor S. L. Windsor D. Diederich n-3 fatty acids and urinary excretion of nitric oxide metabolites in humans Am. J. Clin. Nutr. 1997 65 459 464
84. M. Hashimoto M. S. Hossain H. Yamasaki K. Yazawa S. Masumura Effects of eicosapentaenoic acid and docosahexaenoic acid on plasma membrane fluidity of aortic endothelial cells Lipids 1999 34 1297 1304
85. K. Yin Z. M. Chu L. J. Beilin Study of Mechanisms of Glucocorticoid Hypertension in Rats-Endothelial Related Changes and Their Amelioration by Dietary Fish Oils Br. J. Pharmacol. 1992 106 435 442
86. J. P. F. Chin A. M. Dart How Do Fish Oils Affect Vascular Functions Clin. Exp. Pharmacol. Physiol. 1995 22 71 81
87. P. L. Fox P. E. Dicorleto Fish Oils Inhibit Endothelial-Cell Production of Platelet-Derived Growth-Factor Like Protein Science 1988 241 453 456
88. V. B. Schini W. Durante E. Elizondo T. Scottburden D. C. Junquero A. I. Schafer P. M. Vanhoutte The Induction of Nitric-Oxide Synthase Activity Is Inhibited by Tgf-Beta-1, Pdgfab and Pdgfbb in Vascular Smooth-Muscle Cells Eur. J. Pharmacol. 1992 216 379 383
89. M. Hashimoto K. Shinozuka S. Gamoh Y. Tanabe M. S. Hossain Y. M. Kwon N. Hata Y. Misawa M. Kunitomo S. Masumura The hypotensive effect of docosahexaenoic acid is associated with the enhanced release of ATP from the caudal artery of aged rats J. Nutr. 1999 129 70 76
90. R. Cernes R. Zimlichman M. Shargorodsky Arterial elasticity in cardiovascular disease: Focus on hypertension, metabolic syndrome and diabetes Adv. Cardiol. 2008 45 65 81
91. M. P. Pase N. A. Grima J. Sarris Do long-chain n-3 fatty acids reduce arterial stiffness? A meta-analysis of randomised controlled trials Br. J. Nutr. 2011 106 974 980
92. W. B. Kannel C. Kannel R. S. Paffenbarger Jr L. A. Cupples Heart rate and cardiovascular mortality: the Framingham Study Am. Heart J. 1987 113 1489 1494
93. D. Mozaffarian A. Geelen I. A. Brouwer J. M. Geleijnse P. L. Zock M. B. Katan Effect of fish oil on heart rate in humans-a meta-analysis of randomized controlled trials Circulation 2005 112 1945 1952
94. A. Leaf J. X. Kang Y. F. Xiao G. E. Billman Clinical prevention of sudden cardiac death by n-3 polyunsaturated fatty acids and mechanism of prevention of arrhythmias by n-3 fish oils Circulation 2003 107 2646 2652
95. J. H. Christensen n-3 fatty acids and the risk of sudden cardiac death-Emphasis on heart rate variability Dan. Med. Bull. 2003 50 347 367
96. J. H. Christensen E. B. Schmidt N-3 fatty acids and the risk of sudden cardiac death Lipids 2001 36 S115 S118
97. S. Balanescu A. D. Corlan M. Dorobantu L. Gherasim Prognostic value of heart rate variability after acute myocardial infarction Med. Sci. Monit. 2004 10 Cr307 Cr315
98. J. M. Dekker R. S. Crow A. R. Folsom P. J. Hannan D. Liao C. A. Swenne E. G. Schouten Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes-The ARIC study Circulation 2000 102 1239 1244
99. J. M. Dekker E. G. Schouten P. Klootwijk J. Pool C. A. Swenne D. Kromhout Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men-The zutphen study Am. J. Epidemiol. 1997 145 899 908
100. W. Xin W. Wei X. Y. Li Short-term effects of fish-oil supplementation on heart rate variability in humans: a meta-analysis of randomized controlled trials Am. J. Clin. Nutr. 2013 97 926 935
101. S. Fischer P. C. Weber Thromboxane-A3 (Txa3) Is Formed in Human-Platelets after Dietary Eicosapentaenoic Acid (C2o-5-Omega-3) Biochem. Biophys. Res. Commun. 1983 116 1091 1099
102. H. R. Knapp I. A. Reilly P. Alessandrini G. A. FitzGerald In vivo indexes of platelet and vascular function during fish-oil administration in patients with atherosclerosis N. Engl. J. Med. 1986 314 937 942
103. S. Fischer P. C. Weber Prostaglandin-I3 Is Formed In vivo in Man after Dietary Eicosapentaenoic Acid Nature 1984 307 165 168
104. I. J. Cartwright A. G. Pockley J. H. Galloway M. Greaves F. E. Preston The Effects of Dietary Omega-3 Poly-Unsaturated Fatty-Acids on Erythrocyte-Membrane Phospholipids, Erythrocyte Deformability and Blood-Viscosity in Healthy-Volunteers Atherosclerosis 1985 55 267 281
105. C. von Schacky K. Baumann P. Angerer The effect of n-3 fatty acids on coronary atherosclerosis: Results from SCIMO, an angiographic study, background and implications Lipids 2001 36 S99 S102
106. S. D. Kristensen A. M. B. Iversen E. B. Schmidt n-3 polyunsaturated fatty acids and coronary thrombosis Lipids 2001 36 S79 S82
107. A. H. Lichtenstein Remarks on clinical data concerning dietary supplements that affect antithrombotic therapy Thromb. Res. 2005 117 71 73
108. T. A. Mori L. J. Beilin V. Burke J. Morris J. Ritchie Interactions between dietary fat, fish, and fish oils and their effects on platelet function in men at risk of cardiovascular disease Arterioscler., Thromb., Vasc. Biol. 1997 17 279 286
109. R. J. Woodman T. A. Mori V. Burke I. B. Puddey A. Barden G. F. Watts L. J. Beilin Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients Atherosclerosis 2003 166 85 93
110. T. H. Lee R. L. Hoover J. D. Williams R. I. Sperling J. Ravalese 3rd B. W. Spur D. R. Robinson E. J. Corey R. A. Lewis K. F. Austen Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function N. Engl. J. Med. 1985 312 1217 1224
111. T. A. Mori R. Vandongen F. Mahanian A. Douglas Plasma lipid levels and platelet and neutrophil function in patients with vascular disease following fish oil and olive oil supplementation Metabolism 1992 41 1059 1067
112. R. De Caterina J. K. Liao P. Libby Fatty acid modulation of endothelial activation Am. J. Clin. Nutr. 2000 71 213s 223s
113. G. Bannenberg M. Arita C. N. Serhan Endogenous receptor agonists: resolving inflammation Sci. World J. 2007 7 1440 1462
114. C. N. Serhan Novel eicosanoid and docosanoid mediators: resolvins, docosatrienes, and neuroprotectins Curr. Opin. Clin. Nutr. Metab. Care 2005 8 115 121
115. C. N. Serhan Novel omega-3-derived local mediators in anti-inflammation and resolution Pharmacol. Ther. 2005 105 7 21
116. C. N. Serhan S. D. Brain C. D. Buckley D. W. Gilroy C. Haslett L. A. O'Neill M. Perretti A. G. Rossi J. L. Wallace Resolution of inflammation: state of the art, definitions and terms FASEB J. 2007 21 325 332
117. C. N. Serhan N. Chiang Resolution phase lipid mediators of inflammation: agonists of resolution Curr. Opin. Pharmacol. 2013 13 632 640
118. R. R. Ji Z. Z. Xu G. Strichartz C. N. Serhan Emerging roles of resolvins in the resolution of inflammation and pain Trends Neurosci. 2011 34 599 609
119. C. N. Serhan N. Chiang T. E. Van Dyke Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators Nat. Rev. Immunol. 2008 8 349 361
120. I. Tabas Macrophage death and defective inflammation resolution in atherosclerosis Nat. Rev. Immunol. 2010 10 36 46
121. O. Haworth M. Cernadas R. Yang C. N. Serhan B. D. Levy Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation Nat. Immunol. 2008 9 873 879
122. A. F. Bento R. F. Claudino R. C. Dutra R. Marcon J. B. Calixto Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice J. Immunol. 2011 187 1957 1969
123. Z. Z. Xu R. R. Ji Resolvins are potent analgesics for arthritic pain Br. J. Pharmacol. 2011 164 274 277
124. L. Huang C. F. Wang C. N. Serhan G. Strichartz Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1 Pain 2011 152 557 565
125. E. Mas K. D. Croft P. Zahra A. Barden T. A. Mori Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation Clin. Chem. 2012 58 1476 1484
126. F. Thies J. M. C. Garry P. Yaqoob K. Rerkasem J. Williams C. P. Shearman P. J. Gallagher P. C. Calder R. F. Grimble Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial Lancet 2003 361 477 485
127. C. E. Friedberg M. J. F. M. Janssen R. J. Heine D. E. Grobbee Fish oil and glycemic control in diabetes-A meta-analysis Diabetes Care 1998 21 494 500
128. J. Hartweg R. Perera V. Montori S. Dinneen H. A. W. Neil A. Farmer Omega-3 polyunsaturated fatty acids (PUFA) for type 2 diabetes mellitus Cochrane Database of Systematic Reviews 2008 Artn Cd003205 10.1002/14651858.Cd003205. Pub2
129. V. M. Montori A. Farmer P. C. Wollan S. F. Dinneen Fish oil supplementation in type 2 diabetes-A quantitative systematic review Diabetes Care 2000 23 1407 1415
130. A. O. Akinkuolie J. S. Ngwa J. B. Meigs L. Djousse Omega-3 polyunsaturated fatty acid and insulin sensitivity: A meta-analysis of randomized controlled trials Clin. Nutr. 2011 30 702 707
131. J. H. Y. Wu R. Micha F. Imamura A. Pan M. L. Biggs O. Ajaz L. Djousse F. B. Hu D. Mozaffarian Omega-3 fatty acids and incident type 2 diabetes: a systematic review and meta-analysis Br. J. Nutr. 2012 107 S214 S227
132. T. A. Mori D. W. Dunstan V. Burke K. D. Croft J. H. Rivera L. J. Beilin I. B. Puddey Effect of dietary fish and exercise training on urinary F2-isoprostane excretion in non-insulin-dependent diabetic patients Metabolism 1999 48 1402 1408
133. G. L. Milne H. Yin K. D. Hardy S. S. Davies L. J. Roberts 2nd Isoprostane generation and function Chem. Rev. 2011 111 5973 5996
134. T. A. Mori R. J. Woodman V. Burke I. B. Puddey K. D. Croft L. J. Beilin Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects Free Radical Biol. Med. 2003 35 772 781
135. T. A. Mori I. B. Puddey V. Burke K. D. Croft D. W. Dunstan J. H. Rivera L. J. Beilin Effect of omega 3 fatty acids on oxidative stress in humans: GC-MS measurement of urinary F2-isoprostane excretion Redox Rep. 2000 5 45 46
136. A. E. Barden T. A. Mori J. A. Dunstan A. L. Taylor C. A. Thornton K. D. Croft L. J. Beilin S. L. Prescott Fish oil supplementation in pregnancy lowers F2-isoprostanes in neonates at high risk of atopy Free Radical Res. 2004 38 233 239
137. J. V. Higdon J. K. Liu S. H. Du J. D. Morrow B. N. Ames R. C. Wander Supplementation of postmenopausal women with fish oil rich in eicosapentaenoic acid and docosahexaenoic acid is not associated with greater in vivo lipid peroxidation compared with oils rich in oleate and linoleate as assessed by plasma malondialdehyde and F-2-isoprostanes Am. J. Clin. Nutr. 2000 72 714 722
138. C. Nalsen B. Vessby L. Berglund M. Uusitupa K. Hermansen G. Riccardi A. Rivellese L. Storlien A. Erkkila S. Yla-Herttuala L. Tapsell S. Basu Dietary (n-3) fatty acids reduce plasma F-2-isoprostanes but not prostaglandin F-2 alpha in healthy humans J. Nutr. 2006 136 1222 1228
139. P. Quaggiotto J. W. Leitch J. Falconer R. N. Murdoch M. L. Garg Plasma F-2 alpha-isoprostane levels are lowered in pigs fed an (n-3) polyunsaturated fatty acid supplemented diet following occlusion of the left anterior descending coronary artery Nutr. Res. 2000 20 675 684
140. W. S. Harris C. Von Schacky The Omega-3 Index: a new risk factor for death from coronary heart disease? Prev. Med. 2004 39 212 220
141. R. C. Block W. S. Harris K. J. Reid S. A. Sands J. A. Spertus EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls Atherosclerosis 2008 197 821 828
142. J. V. Pottala S. Garg B. E. Cohen M. A. Whooley W. S. Harris Blood Eicosapentaenoic and Docosahexaenoic Acids Predict All-Cause Mortality in Patients With Stable Coronary Heart Disease The Heart and Soul Study Circ. Cardiovasc Qual. Outcomes 2010 3 406 412
143. H. E. Bays Safety considerations with omega-3 fatty acid therapy Am. J. Cardiol. 2007 99 35C 43C
144. P. D. Watson P. S. Joy C. Nkonde S. E. Hessen D. G. Karalis Comparison of bleeding complications with omega-3 fatty acids + aspirin + clopidogrel-versus-aspirin + clopidogrel in patients with cardiovascular disease Am. J. Cardiol. 2009 104 1052 1054
145. W. S. Harris Expert opinion: omega-3 fatty acids and bleeding-cause for concern? Am. J. Cardiol. 2007 99 44C 46C
146. A. R. Heller S. Fischer T. Rossel S. Geiger G. Siegert M. Ragaller T. Zimmermann T. Koch Impact of n-3 fatty acid supplemented parenteral nutrition on haemostasis patterns after major abdominal surgery Br. J. Nutr. 2002 87 S95 S101
147. P. M. Kris-Etherton W. S. Harris L. J. Appel N. Comm Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease Circulation 2002 106 2747 2757
148. M. Lucas G. Asselin M. Plourde S. C. Cunnane E. Dewailly S. Dodin n-3 Fatty acid intake from marine food products among Quebecers: comparison to worldwide recommendations Public Health Nutr. 2010 13 63 70
149. S. K. Gebauer T. L. Psota W. S. Harris P. M. Kris-Etherton n-3 fatty acid dietary recommendations and food sources to achieve essentiality and cardiovascular benefits Am. J. Clin. Nutr. 2006 83 1526s 1535s
150. B. Koletzko I. Cetin J. T. Brenna P. Grp Dietary fat intakes for pregnant and lactating women Br. J. Nutr. 2007 98 873 877
151. A. P. Simopoulos A. Leaf N. Salem Jr Workshop statement on the essentiality of and recommended dietary intakes for Omega-6 and Omega-3 fatty acids Prostaglandins, Leukotrienes Essent. Fatty Acids 2000 63 119 121
152. D. M. Lloyd-Jones Y. L. Hong D. Labarthe D. Mozaffarian L. J. Appel L. Van Horn K. Greenlund S. Daniels G. Nichol G. F. Tomaselli D. K. Arnett G. C. Fonarow P. M. Ho M. S. Lauer F. A. Masoudi R. M. Robertson V. Roger L. H. Schwamm P. Sorlie C. W. Yancy W. D. Rosamond A. H. A. S. Plannin Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction The American Heart Association's Strategic Impact Goal Through 2020 and Beyond Circulation 2010 121 586 613